Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2400093	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2024-04-24					view
JXSS2400040	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18					view
JXSS2400038	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18					view
CXSL2300420	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2023-06-19		Innovent Biologics (Suzhou) Co Ltd			view
JYSB2300110	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2023-06-17					view
JYSB2300080	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2023-04-29					view
JXSB2101089	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-11-12					view
JXSB2101090	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-11-12					view
JYSB2101118	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-08-31					view
JYSB2101119	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-08-31					view
CXSL2101073	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2021-05-14		Innovent Biologics (Suzhou) Co Ltd			view
JXSB2101005	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Supplementary Application	2021-04-28					view
JTS2100019	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Disposable Import Drug Application	2021-02-25	Bristol-Myers Squibb Holdings Pharma, Ltd.Liability Company	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-03-16	view
JTS2000062	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Disposable Import Drug Application	2021-01-01	苏州信达生物科技有限公司	Suzhou Xinda Biotechnology Co Ltd	Pending Approval	2021-06-22	view
JXSS2000055	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(3.1)	Import Drug Application	2020-12-03			In Review	2020-12-02	view
JXSS2000056	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(3.1)	Import Drug Application	2020-12-03			In Review	2020-12-02	view
JTS2000041	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Disposable Import Drug Application	2020-09-24	Bristol-Myers Squibb Holdings Pharma, Ltd.Liability Company	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2020-10-21	view
JXSB2000016	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2020-09-19			In Review	2020-09-18	view
CXSL2000233	IBI310	ipilimumab	Injection	Biological Products(3.3)	New Drug Application	2020-08-12	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-11	view
CXSL2000231	IBI310	ipilimumab	Injection	Biological Products(3.3)	New Drug Application	2020-08-12	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-11	view